CGT-focused CDMOs support the future of biomanufacturing through advanced facilities, skilled technical teams, and integrated services. These organizations help biotech companies manage complex cell and gene therapy production, ensure regulatory compliance, reduce operational risks, and accelerate the development and commercialization of innovative therapies for patients worldwide. https://xelleratherapeutic.wixsite.com/xellera-therapeutics/post/why-cgt-focused-cdmos-are-the-future-of-biomanufacturing